C660-0295 Screening compound: 2-{1-oxo-4-[(pyridin-4-yl)methyl]-1,2-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide

C660-0295 Screening compound: 2-{1-oxo-4-[(pyridin-4-yl)methyl]-1,2-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide
C660-0295 Screening compound: 2-{1-oxo-4-[(pyridin-4-yl)methyl]-1,2-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C660-0295
2-{1-oxo-4-[(pyridin-4-yl)methyl]-1,2-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C660-0295

Molecular Formula

C29H32N6O2 (C29 H32 N6 O2)

Compound Name

2-{1-oxo-4-[(pyridin-4-yl)methyl]-1,2-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide

IUPAC name

2-{1-oxo-4-[(pyridin-4-yl)methyl]-12-dihydrophthalazin-2-yl}-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide

SMILES

O=C(CN1N=C(Cc2ccncc2)c(cccc2)c2C1=O)NCCCN(CC1)CCN1c1ccccc1

InChI

InChI=1S/C29H32N6O2/c36-28(31-13-6-16-33-17-19-34(20-18-33)24-7-2-1-3-8-24)22-35-29(37)26-10-5-4-9-25(26)27(32-35)21-23-11-14-30-15-12-23/h1-5,7-12,14-15H,6,13,16-22H2,(H,31,36)

InChI Key

OPNVKIWPYCFQRF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14780021

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.61

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.786

Distribution Coefficient, logD

1.200

Water Solubility, LogSw

-2.40

Polar Surface Area

68.083

Acid Dissociation Constant (pKa)

16.14

Base Dissociation Constant (pKb)

7.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

C660-0295 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C660-0295 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C660-0295?
Check Price and Availability of C660-0295, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C660-0295 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C660-0295
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C660-0295
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C660-0295 available by request